Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 63

    1.

    A genome-wide association study identifies a novel major locus for glycemic control in type 1 diabetes, as measured by both HbA1c and glucose.

    Paterson AD, Waggott D, Boright AP, Hosseini SM, Shen E, Sylvestre MP, Wong I, Bharaj B, Cleary PA, Lachin JM; MAGIC, Below JE, Nicolae D, Cox NJ, Canty AJ, Sun L, Bull SB; The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes. 2009 Oct 29. [Epub ahead of print]PMID: 19875614 [PubMed - as supplied by publisher]Related articles

    2.

    Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005).

    Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group, Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ.

    Arch Intern Med. 2009 Jul 27;169(14):1307-16.PMID: 19636033 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC).

    Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, Sommer C, Cleary PA, Lachin JM, Herman WH; DCCT/EDIC Research Group.

    Circulation. 2009 Jun 9;119(22):2886-93. Epub 2009 May 26.PMID: 19470886 [PubMed - in process]Related articles

    4.

    Sexual dysfunction in women with type 1 diabetes: long-term findings from the DCCT/ EDIC study cohort.

    Enzlin P, Rosen R, Wiegel M, Brown J, Wessells H, Gatcomb P, Rutledge B, Chan KL, Cleary PA; DCCT/EDIC Research Group.

    Diabetes Care. 2009 May;32(5):780-5.PMID: 19407075 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Risk factors for urinary incontinence among women with type 1 diabetes: findings from the epidemiology of diabetes interventions and complications study.

    Sarma AV, Kanaya A, Nyberg LM, Kusek JW, Vittinghoff E, Rutledge B, Cleary PA, Gatcomb P, Brown JS; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Urology. 2009 Jun;73(6):1203-9. Epub 2009 Apr 10.PMID: 19362350 [PubMed - indexed for MEDLINE]Related articles

    6.

    Glycemic control and hypoglycemia: is the loser the winner? Response to Perlmuter et al.

    Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes Care. 2009 Apr;32(4):e46; discussion e47. No abstract available. PMID: 19336634 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.

    Van Den Eeden SK, Sarma AV, Rutledge BN, Cleary PA, Kusek JW, Nyberg LM, McVary KT, Wessells H; Diabetes Control and Complications Trial/Epidemiology of Diabetes Research Group.

    Diabetes Care. 2009 Apr;32(4):664-70. Epub 2009 Jan 26.PMID: 19171725 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Urinary incontinence among women with type 1 diabetes--how common is it?

    Sarma AV, Kanaya AM, Nyberg LM, Kusek JW, Vittinghoff E, Rutledge B, Cleary PA, Gatcomb P, Brown JS; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    J Urol. 2009 Mar;181(3):1224-30; discussion 1230. Epub 2009 Jan 18.PMID: 19152930 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.

    Czaja CA, Rutledge BN, Cleary PA, Chan K, Stapleton AE, Stamm WE; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    J Urol. 2009 Mar;181(3):1129-34; discussion 1134-5. Epub 2009 Jan 18.PMID: 19152925 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Association of diet with glycated hemoglobin during intensive treatment of type 1 diabetes in the Diabetes Control and Complications Trial.

    Delahanty LM, Nathan DM, Lachin JM, Hu FB, Cleary PA, Ziegler GK, Wylie-Rosett J, Wexler DJ; Diabetes Control and Complications Trial/Epidemiology of Diabetes.

    Am J Clin Nutr. 2009 Feb;89(2):518-24. Epub 2008 Dec 23.PMID: 19106241 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.

    White NH, Sun W, Cleary PA, Danis RP, Davis MD, Hainsworth DP, Hubbard LD, Lachin JM, Nathan DM.

    Arch Ophthalmol. 2008 Dec;126(12):1707-15.PMID: 19064853 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus.

    de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.

    Arch Intern Med. 2008 Sep 22;168(17):1867-73.PMID: 18809813 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Impact of diabetes and its treatment on cognitive function among adolescents who participated in the Diabetes Control and Complications Trial.

    Musen G, Jacobson AM, Ryan CM, Cleary PA, Waberski BH, Weinger K, Dahms W, Bayless M, Silvers N, Harth J, White N; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes Care. 2008 Oct;31(10):1933-8. Epub 2008 Jul 7.PMID: 18606979 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Electronic quenching of OH A 2Sigma+ radicals in single collision events with H2 and D2: a comprehensive quantum state distribution of the OH X 2Pi products.

    Dempsey LP, Murray C, Cleary PA, Lester MI.

    Phys Chem Chem Phys. 2008 Mar 14;10(10):1424-32. Epub 2007 Nov 30.PMID: 18309399 [PubMed - indexed for MEDLINE]Related articles

    15.

    Pulsed Laval nozzle study of the kinetics of OH with unsaturated hydrocarbons at very low temperatures.

    Taylor SE, Goddard A, Blitz MA, Cleary PA, Heard DE.

    Phys Chem Chem Phys. 2008 Jan 21;10(3):422-37. Epub 2007 Nov 7.PMID: 18174984 [PubMed]Related articles

    16.

    Nephropathy in type 1 diabetes is diminished in carriers of HLA-DRB1*04: the genetics of kidneys in diabetes (GoKinD) study.

    Cordovado SK, Zhao Y, Warram JH, Gong H, Anderson KL, Hendrix MM, Hancock LN, Cleary PA, Mueller PW.

    Diabetes. 2008 Feb;57(2):518-22. Epub 2007 Nov 26.PMID: 18039812 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Multiple superoxide dismutase 1/splicing factor serine alanine 15 variants are associated with the development and progression of diabetic nephropathy: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Genetics study.

    Al-Kateb H, Boright AP, Mirea L, Xie X, Sutradhar R, Mowjoodi A, Bharaj B, Liu M, Bucksa JM, Arends VL, Steffes MW, Cleary PA, Sun W, Lachin JM, Thorner PS, Ho M, McKnight AJ, Maxwell AP, Savage DA, Kidd KK, Kidd JR, Speed WC, Orchard TJ, Miller RG, Sun L, Bull SB, Paterson AD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes. 2008 Jan;57(1):218-28. Epub 2007 Oct 3.PMID: 17914031 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Metal-catalyzed silylene insertions of allylic ethers: stereoselective formation of chiral allylic silanes.

    Bourque LE, Cleary PA, Woerpel KA.

    J Am Chem Soc. 2007 Oct 24;129(42):12602-3. Epub 2007 Sep 28. No abstract available. PMID: 17900189 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intensive treatment of diabetes is associated with a reduced rate of peripheral arterial calcification in the diabetes control and complications trial.

    Carter RE, Lackland DT, Cleary PA, Yim E, Lopes-Virella MF, Gilbert GE, Orchard TJ; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.

    Diabetes Care. 2007 Oct;30(10):2646-8. Epub 2007 Jul 10. No abstract available. PMID: 17623823 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Electronic quenching of OH A 2Sigma+ radicals in single collision events with molecular hydrogen: quantum state distribution of the OH X 2Pi products.

    Cleary PA, Dempsey LP, Murray C, Lester MI, Kłos J, Alexander MH.

    J Chem Phys. 2007 May 28;126(20):204316.PMID: 17552771 [PubMed]Related articles

    21.

    The effect of intensive diabetes treatment on resting heart rate in type 1 diabetes: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study.

    Paterson AD, Rutledge BN, Cleary PA, Lachin JM, Crow RS; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group.

    Diabetes Care. 2007 Aug;30(8):2107-12. Epub 2007 Apr 27.PMID: 17468351 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Experimental and master equation study of the kinetics of OH + C2H2: temperature dependence of the limiting high pressure and pressure dependent rate coefficients.

    McKee KW, Blitz MA, Cleary PA, Glowacki DR, Pilling MJ, Seakins PW, Wang L.

    J Phys Chem A. 2007 May 17;111(19):4043-55. Epub 2007 Mar 31.PMID: 17397143 [PubMed]Related articles

    23.

    Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study.

    de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group.

    J Am Soc Nephrol. 2007 Jan;18(1):235-43. Epub 2006 Dec 6.PMID: 17151331 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Determination of the temperature and pressure dependence of the reaction OH + C2H4 from 200-400 K using experimental and master equation analyses.

    Cleary PA, Romero MT, Blitz MA, Heard DE, Pilling MJ, Seakins PW, Wang L.

    Phys Chem Chem Phys. 2006 Dec 28;8(48):5633-42. Epub 2006 Nov 15.PMID: 17149484 [PubMed - indexed for MEDLINE]Related articles

    25.

    The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.

    Cleary PA, Orchard TJ, Genuth S, Wong ND, Detrano R, Backlund JY, Zinman B, Jacobson A, Sun W, Lachin JM, Nathan DM; DCCT/EDIC Research Group.

    Diabetes. 2006 Dec;55(12):3556-65.PMID: 17130504 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Genetics of Kidneys in Diabetes (GoKinD) study: a genetics collection available for identifying genetic susceptibility factors for diabetic nephropathy in type 1 diabetes.

    Mueller PW, Rogus JJ, Cleary PA, Zhao Y, Smiles AM, Steffes MW, Bucksa J, Gibson TB, Cordovado SK, Krolewski AS, Nierras CR, Warram JH.

    J Am Soc Nephrol. 2006 Jul;17(7):1782-90. Epub 2006 Jun 14.PMID: 16775037 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Convergent, stereoselective synthesis of the GHIJ fragment of brevetoxin A.

    Crimmins MT, Zuccarello JL, Cleary PA, Parrish JD.

    Org Lett. 2006 Jan 5;8(1):159-62.PMID: 16381592 [PubMed - indexed for MEDLINE]Related articles

    28.

    Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

    Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, Raskin P, Zinman B; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group.

    N Engl J Med. 2005 Dec 22;353(25):2643-53.PMID: 16371630 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Metal-catalyzed rearrangement of homoallylic ethers to silylmethyl allylic silanes in the presence of a Di-tert-butylsilylene source.

    Cleary PA, Woerpel KA.

    Org Lett. 2005 Nov 24;7(24):5531-3.PMID: 16288549 [PubMed - indexed for MEDLINE]Related articles

    30.

    Relationship of family history of type 2 diabetes, hypoglycemia, and autoantibodies to weight gain and lipids with intensive and conventional therapy in the Diabetes Control and Complications Trial.

    Purnell JQ, Dev RK, Steffes MW, Cleary PA, Palmer JP, Hirsch IB, Hokanson JE, Brunzell JD.

    Diabetes. 2003 Oct;52(10):2623-9.PMID: 14514648 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Laser-induced fluorescence detection of atmospheric NO2 with a commercial diode laser and a supersonic expansion.

    Cleary PA, Wooldridge PJ, Cohen RC.

    Appl Opt. 2002 Nov 20;41(33):6950-6.PMID: 12463239 [PubMed]Related articles

    32.

    Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT).

    White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group.

    J Pediatr. 2001 Dec;139(6):804-12.PMID: 11743505 [PubMed - indexed for MEDLINE]Related articles

    33.

    Increased small dense LDL and intermediate-density lipoprotein with albuminuria in type 1 diabetes.

    Sibley SD, Hokanson JE, Steffes MW, Purnell JQ, Marcovina SM, Cleary PA, Brunzell JD.

    Diabetes Care. 1999 Jul;22(7):1165-70. Erratum in: Diabetes Care 1999 Sep;22(9):1601. PMID: 10388983 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial.

    Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD.

    JAMA. 1998 Jul 8;280(2):140-6. Erratum in: JAMA 1998 Nov 4;280(17):1484. PMID: 9669786 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Visual symptoms after optic neuritis. Results from the Optic Neuritis Treatment Trial.

    Cleary PA, Beck RW, Bourque LB, Backlund JC, Miskala PH.

    J Neuroophthalmol. 1997 Mar;17(1):18-23; quiz 24-8.PMID: 9093956 [PubMed - indexed for MEDLINE]Related articles

    37.

    Contrast sensitivity and other vision tests in the optic neuritis treatment trial.

    Trobe JD, Beck RW, Moke PS, Cleary PA.

    Am J Ophthalmol. 1996 May;121(5):547-53.PMID: 8610798 [PubMed - indexed for MEDLINE]Related articles

    38.

    Levels of lipoprotein(a), apolipoprotein B, and lipoprotein cholesterol distribution in IDDM. Results from follow-up in the Diabetes Control and Complications Trial.

    Purnell JQ, Marcovina SM, Hokanson JE, Kennedy H, Cleary PA, Steffes MW, Brunzell JD.

    Diabetes. 1995 Oct;44(10):1218-26.PMID: 7556961 [PubMed - indexed for MEDLINE]Related articles

    39.

    Reproducibility of a comprehensive diet history in the Diabetes Control and Complications Trial. The DCCT Research Group.

    Schmidt LE, Cox MS, Buzzard IM, Cleary PA.

    J Am Diet Assoc. 1994 Dec;94(12):1392-7.PMID: 7963189 [PubMed - indexed for MEDLINE]Related articles

    40.

    The use of bioelectrical impedance analysis (BIA) to estimate body composition in the Diabetes Control and Complications Trial (DCCT).

    Leiter LA, Lukaski HC, Kenny DJ, Barnie A, Camelon K, Ferguson RS, MacLean S, Simkins S, Zinman B, Cleary PA.

    Int J Obes Relat Metab Disord. 1994 Dec;18(12):829-35.PMID: 7894522 [PubMed - indexed for MEDLINE]Related articles

    41.

    The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.

    Beck RW, Cleary PA, Backlund JC.

    Ophthalmology. 1994 Nov;101(11):1771-8.PMID: 7800355 [PubMed - indexed for MEDLINE]Related articles

    42.

    The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.

    Beck RW, Cleary PA, Trobe JD, Kaufman DI, Kupersmith MJ, Paty DW, Brown CH.

    N Engl J Med. 1993 Dec 9;329(24):1764-9.PMID: 8232485 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Glomerular filtration rate measurements in clinical trials. Modification of Diet in Renal Disease Study Group and the Diabetes Control and Complications Trial Research Group.

    Levey AS, Greene T, Schluchter MD, Cleary PA, Teschan PE, Lorenz RA, Molitch ME, Mitch WE, Siebert C, Hall PM, et al.

    J Am Soc Nephrol. 1993 Nov;4(5):1159-71.PMID: 8305642 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group.

    Beck RW, Arrington J, Murtagh FR, Cleary PA, Kaufman DI.

    Arch Neurol. 1993 Aug;50(8):841-6.PMID: 8352671 [PubMed - indexed for MEDLINE]Related articles

    45.

    Optic neuritis treatment trial. One-year follow-up results.

    Beck RW, Cleary PA.

    Arch Ophthalmol. 1993 Jun;111(6):773-5.PMID: 8512477 [PubMed - indexed for MEDLINE]Related articles

    46.

    Fellow eye abnormalities in acute unilateral optic neuritis. Experience of the optic neuritis treatment trial.

    Beck RW, Kupersmith MJ, Cleary PA, Katz B.

    Ophthalmology. 1993 May;100(5):691-7; discussion 697-8.PMID: 8493012 [PubMed - indexed for MEDLINE]Related articles

    47.

    Side effects of glucocorticoid treatment. Experience of the Optic Neuritis Treatment Trial.

    Chrousos GA, Kattah JC, Beck RW, Cleary PA.

    JAMA. 1993 Apr 28;269(16):2110-2.PMID: 8468765 [PubMed - indexed for MEDLINE]Related articles

    48.

    Quality control functions of the Visual Field Reading Center (VFRC) for the Optic Neuritis Treatment Trial (ONTT).

    Keltner JL, Johnson CA, Beck RW, Cleary PA, Spurr JO.

    Control Clin Trials. 1993 Apr;14(2):143-59.PMID: 8500303 [PubMed - indexed for MEDLINE]Related articles

    49.

    Design, methods, and conduct of the Optic Neuritis Treatment Trial.

    Cleary PA, Beck RW, Anderson MM Jr, Kenny DJ, Backlund JY, Gilbert PR.

    Control Clin Trials. 1993 Apr;14(2):123-42.PMID: 8500302 [PubMed - indexed for MEDLINE]Related articles

    50.

    Baseline analysis of renal function in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group [corrected]

    Molitch ME, Steffes MW, Cleary PA, Nathan DM.

    Kidney Int. 1993 Mar;43(3):668-74. Erratum in: Kidney Int 1993 May;43(5):1196. PMID: 8455366 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...